Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue

Immune checkpoint inhibitors have become a promising new therapy for cancer treatment. However, due to prostate cancer’s high heterogeneity and immune-suppressive tumour microenvironment, clinical trials with immune checkpoint inhibitors for prostate cancer resulted in low or no response. This descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Ulrich, Ebersbach, Celina, Beier, Alicia-Marie K., Baretton, Gustavo B., Thomas, Christian, Borkowetz, Angelika, Erb, Holger H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273856/
https://www.ncbi.nlm.nih.gov/pubmed/35836932
http://dx.doi.org/10.3389/fmolb.2022.878353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273856/
https://www.ncbi.nlm.nih.gov/pubmed/35836932
http://dx.doi.org/10.3389/fmolb.2022.878353

Ejemplares similares